MP
Mehul Pravin Shah
About Mehul Pravin Shah
Data last updated:
Mehul Pravin Shah has 21 years in corporate governance. Holds Director and Designated Partner roles. Currently with 11 companies, including Blisson Mediplus Private Limited and Swasth Edible Oils Limited. Formerly with 8 companies, such as Embrion Art Surat Llp and Bioaltus Pharmaceuticals Private Limited. Engaged in General Business, Technology and more. The 6 current companies with reported revenue have a combined latest revenue of ₹346 Cr; the largest is Precise Biopharma Private Limited at ₹201 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Precise Biopharma Private Limited U24230MH2005PTC152453 | Director | 06 Apr 2005 | 2005 | ₹201 Cr (FY 2025) | Active |
| Precise Chemipharma P Ltd U24110MH1993PTC075033 | Director | 01 Jun 2024 | 1993 | ₹48.20 Cr (FY 2025) | Active |
 Blisson Mediplus Private Limited U11100MH2013PTC244233 | Director | 10 Jun 2013 | 2013 | ₹44.12 Cr (FY 2024) | Active |
 Blisson Medica Private Limited U24290MH2019PTC325171 | Director | 09 May 2019 | 2019 | ₹43.99 Cr (FY 2024) | Active |
 Cyrus Remedies Private Limited U24110MH2021PTC365048 | Director | 02 Aug 2021 | 2021 | ₹8.41 Cr (FY 2024) | Active |
 Suremed Lifecare Private Limited U85191MH2011PTC216142 | Director | 16 Jan 2014 | 2011 | ₹19.4 Lakh (FY 2025) | Active |
| Bmedica One Llp ACS-5567 | Designated Partner | 10 Nov 2025 | 2025 | – | Active |
| Bmediplus One Llp ACQ-4182 | Designated Partner | 06 Aug 2025 | 2025 | – | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Embrion Art Surat Llp AAJ-6043 | Designated Partner | 05 Jun 2017 | 2017 | – | Active |
 Bioaltus Pharmaceuticals Private Limited U74900MH2014PTC254786 | Director | 15 Jan 2021 | 2014 | ₹118 Cr (FY 2025) | Active |
| Stembrella Precise Healthcare Private Limited U74900DL2016PTC291197 | Director | 16 Feb 2016 | 2016 | ₹94 Lakh (FY 2025) | Active |
| Priserve Infratech Limited U72300MH2013PLC239560 | Director | 11 Jan 2013 | 2013 | – | Strike Off |
| Embrion Art Private Limited U85300GJ2017PTC096747 | Director | 07 Apr 2017 | 2017 | ₹45.4 Lakh (FY 2025) | Active |
| Construee Solutions Private Limited U74999MH2011PTC217269 | Director | 10 May 2011 | 2011 | – | Active |
| Swasth Edible Oils Limited U15400MH2012PLC236904 | Director | 17 Oct 2012 | 2012 | – | Strike Off |
| Cenesys Care India Private Limited U24100TN2013PTC089301 | Director | 08 Jan 2013 | 2013 | – | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Mehul Pravin Shah
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mehul Pravin Shah
Mehul Pravin Shah has 21 years in corporate governance. Holds Director and Designated Partner roles. Currently with 11 companies, including Blisson Mediplus Private Limited and Swasth Edible Oils Limited. Formerly with 8 companies, such as Embrion Art Surat Llp and Bioaltus Pharmaceuticals Private Limited. Engaged in General Business, Technology and more. The 6 current companies with reported revenue have a combined latest revenue of ₹346 Cr; the largest is Precise Biopharma Private Limited at ₹201 Cr (FY 2025).
Mehul Pravin Shah is associated with 11 companies as Director and Designated Partner, including Precise Biopharma Private Limited (₹201 Cr), Precise Chemipharma P Ltd (₹48.20 Cr), Blisson Mediplus Private Limited (₹44.12 Cr).
Mehul Pravin Shah has expertise in General Business, Technology and other sectors.
Mehul Pravin Shah has 21 years in corporate governance.
By reported revenue, the largest current company of Mehul Pravin Shah is Precise Biopharma Private Limited, with revenue of ₹201 Cr (FY 2025).
The 6 current companies of Mehul Pravin Shah that report revenue have a combined latest revenue of ₹346 Cr.
Mehul Pravin Shah currently holds positions at 11 companies; the 5 largest by reported revenue are Precise Biopharma Private Limited (₹201 Cr), Precise Chemipharma P Ltd (₹48.20 Cr), Blisson Mediplus Private Limited (₹44.12 Cr), Blisson Medica Private Limited (₹43.99 Cr), Cyrus Remedies Private Limited (₹8.41 Cr).